siRNA transfection

ST Simon Timbrell
HA Hosam Aglan
AC Angela Cramer
PF Phil Foden
DW David Weaver
JP Jonathan Pachter
AK Aoife Kilgallon
RC Robert B. Clarke
GF Gillian Farnie
NB Nigel J. Bundred
request Request a Protocol
ask Ask a question
Favorite

A set of four individual pre-designed siRNA’s targeting PTK2 (the gene encoding for FAK) were purchased from Dharmacon alongside positive control GAPDH and scrambled negative control. A range of concentrations of siRNA (25–50 nM) were trialled, at a range of different time points (48–72 h), on a range of different cell densities 10,000, 50,000, and 100,000 cells per 10 cm2 plate for MDA-MB 231 and SUM159 cells. siRNA constructs were used as single agents and in combination with the effect on tFAK expression measured by western blot analysis. Cells were seeded 24–48 h prior to transfection and washed prior to exposure to transfection media. The siRNA transfection media was prepared by adding 10 µl of siRNA and 190 µl of serum-free media to one tube and 10 µl of transfection reagent to 190 µl of serum free media in another tube. These separate tubes were incubated at room temperature for 5 min prior to mixing. Once mixed this solution was incubated for a further 20 min at room temperature prior to the addition of a further 1600 µl of DMEM media containing FCS and l-glutamine. This created a 50 nM solution in 2 ml of media, which was added to a 10 cm2 culture plate. Cells were incubated with this media for 48–96 h. After a maximum of 96 h cells were then collected for western blot analysis or isolated as single cells for mammosphere culture and Aldefluor expression analysis.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A